Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
NCT ID: NCT06549621
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
66 participants
OBSERVATIONAL
2022-07-25
2024-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to investigate the early and late cardiologic effects of CO in patients treated with hyperbaric oxygen (HBOT) for CO poisoning
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbon Monoxide-induced Coma: Prognostic Factors
NCT03926494
Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning
NCT01100515
Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning
NCT01099995
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
NCT04490317
Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
NCT04656912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One month between the start of theses interviews, an information letter on the study is sent by post, giving the possibility of opposing it.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anne Henckes
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COCARDIOTOX (29BRC22.0049)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.